This analysis demonstrates how clonal hematopoiesis and ferritin levels predict hematologic toxicity, suggesting potential implications for patient management in CAR T-cell treatments.
Figure S3. (A-B) Progression-free survival (A) and overall survival (B) stratified by baseline ferritin (ferr.) and clonal hematopoiesis (CH), with estimated median and/or 24-month survival and hazard ratios (HR) with 95% confidence intervals (CI) shown. NR, not reached.
No takes yet. Share an insight, caveat, or question.
Avigan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: